{"schema_version":"secwatch.filing_event.v1","accession":"0001171843-24-000099","form_type":"8-K","ticker":"HBIO","cik":"0001123494","company_name":"HARVARD BIOSCIENCE INC","filed_at":"2024-01-05T23:59:59+00:00","discovered_at":"2026-05-14T18:03:23.449870+00:00","generated_at":"2026-06-07T02:55:05.815142+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Harvard Bioscience prelim FY2023 revenue ~$112.3M; includes $5.1M discontinued product headwind","bullets":["Preliminary unaudited FY2023 revenue estimate of ~$112.3M, down from $113.3M in FY2022, with $5.1M net headwind from discontinued products.","Adjusted EBITDA for YTD Q3 2023 was $10.9M (13% of revenue), up 53% vs prior year; FY2022 adjusted EBITDA margin was 9.6%.","Company cites Covid portfolio optimization and supply chain challenges as revenue headwinds.","Guidance from Q3 2023 earnings (Nov 7, 2023) was for FY23 revenue down 11-14%; this presentation does not reaffirm guidance."],"urls":{"canonical":"https://secwatch.observer/filing/0001171843-24-000099","json":"https://secwatch.observer/filing/0001171843-24-000099.json","markdown":"https://secwatch.observer/filing/0001171843-24-000099.md","text":"https://secwatch.observer/filing/0001171843-24-000099.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1123494/000117184324000099/0001171843-24-000099-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1123494/000117184324000099/f8k_010524.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-07T02:55:05.815142+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"ba8091a5cb576ca7ae65c2be8c3b4247518453fc","claim":"HARVARD BIOSCIENCE INC reported full year 2023 results: revenue ~ $112.3M incl. $5.1M net discontinued*.","evidence_excerpt":"Est. FY’23 Revenue: ~ $112.3M incl. $5.1M net discontinued*","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1123494/000117184324000099/0001171843-24-000099-index.htm","confidence":0.7,"family_label":"Earnings Releases","details":[{"label":"Period","value":"full year 2023"},{"label":"Revenue","value":"~ $112.3M incl. $5.1M net discontinued*"},{"label":"Result","value":"preliminary results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}